Bell Rock Capital LLC Lowers Position in Clorox Co (CLX)

Bell Rock Capital LLC lessened its stake in Clorox Co (NYSE:CLX) by 13.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,314 shares of the company’s stock after selling 1,276 shares during the quarter. Bell Rock Capital LLC’s holdings in Clorox were worth $1,334,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Athena Capital Advisors LLC acquired a new position in shares of Clorox during the fourth quarter worth about $25,000. Meeder Asset Management Inc. acquired a new position in shares of Clorox during the fourth quarter worth about $26,000. Capital Financial Planning LLC acquired a new position in shares of Clorox during the fourth quarter worth about $32,000. City Holding Co. boosted its position in shares of Clorox by 150.0% during the fourth quarter. City Holding Co. now owns 250 shares of the company’s stock worth $39,000 after buying an additional 150 shares during the period. Finally, G&S Capital LLC boosted its position in shares of Clorox by 46.4% during the fourth quarter. G&S Capital LLC now owns 262 shares of the company’s stock worth $40,000 after buying an additional 83 shares during the period. Institutional investors and hedge funds own 76.89% of the company’s stock.

CLX has been the subject of several recent research reports. BMO Capital Markets set a $175.00 price objective on Clorox and gave the stock a “buy” rating in a research report on Tuesday, February 5th. Credit Suisse Group assumed coverage on Clorox in a research report on Wednesday, March 6th. They set an “outperform” rating and a $172.00 price target for the company. Barclays reissued a “hold” rating and set a $142.00 price target on shares of Clorox in a research report on Wednesday, February 6th. Wells Fargo & Co reissued a “hold” rating and set a $157.00 price target on shares of Clorox in a research report on Thursday, February 21st. Finally, Citigroup set a $171.00 price target on Clorox and gave the company a “hold” rating in a research report on Tuesday, February 5th. Six investment analysts have rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company. Clorox presently has a consensus rating of “Hold” and a consensus price target of $151.21.

In other Clorox news, SVP Andrew J. Mowery sold 5,340 shares of the firm’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $156.44, for a total value of $835,389.60. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Matthew T. Laszlo sold 10,585 shares of the firm’s stock in a transaction on Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total value of $1,628,925.65. Following the completion of the sale, the senior vice president now directly owns 17,994 shares in the company, valued at approximately $2,769,096.66. The disclosure for this sale can be found here. Corporate insiders own 1.40% of the company’s stock.

NYSE:CLX traded down $1.04 on Monday, hitting $154.45. The company’s stock had a trading volume of 743,658 shares, compared to its average volume of 990,273. The company has a quick ratio of 0.66, a current ratio of 1.15 and a debt-to-equity ratio of 3.08. The firm has a market capitalization of $19.87 billion, a price-to-earnings ratio of 24.67, a P/E/G ratio of 3.87 and a beta of 0.32. Clorox Co has a one year low of $113.57 and a one year high of $167.70.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 4th. The company reported $1.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.32 by $0.08. The company had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.47 billion. Clorox had a return on equity of 105.97% and a net margin of 12.65%. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.77 earnings per share. Equities research analysts expect that Clorox Co will post 6.31 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a dividend of $0.96 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.49%. Clorox’s dividend payout ratio (DPR) is currently 61.34%.

WARNING: “Bell Rock Capital LLC Lowers Position in Clorox Co (CLX)” was reported by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.baseballdailydigest.com/news/2019/04/15/bell-rock-capital-llc-decreases-holdings-in-clorox-co-clx.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: How is a buy-side analyst different from a sell-side analyst?

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.